Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126849691 | 12684969 | 1 | I | 20140530 | 20160816 | 20160825 | 20160825 | EXP | US-JNJFOC-20160813971 | JANSSEN | 51.13 | YR | A | M | Y | 87.50000 | KG | 20160825 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126849691 | 12684969 | 1 | PS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | N | 21976 | 600 | MG | TABLETS | BID | ||||||
| 126849691 | 12684969 | 2 | SS | MARAVIROC | MARAVIROC | 1 | Unknown | 0 | 150 | MG | UNSPECIFIED | BID | |||||||
| 126849691 | 12684969 | 3 | SS | NORVIR | RITONAVIR | 1 | Unknown | 0 | 100 | MG | UNSPECIFIED | BID | |||||||
| 126849691 | 12684969 | 4 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 0 | 500 | MG | UNSPECIFIED | QD | |||||||
| 126849691 | 12684969 | 5 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 126849691 | 12684969 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 126849691 | 12684969 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 126849691 | 12684969 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126849691 | 12684969 | 1 | Product used for unknown indication |
| 126849691 | 12684969 | 2 | Product used for unknown indication |
| 126849691 | 12684969 | 3 | Product used for unknown indication |
| 126849691 | 12684969 | 4 | Product used for unknown indication |
| 126849691 | 12684969 | 5 | Prophylaxis |
| 126849691 | 12684969 | 6 | Hyperlipidaemia |
| 126849691 | 12684969 | 7 | Diabetes mellitus |
| 126849691 | 12684969 | 8 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126849691 | 12684969 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126849691 | 12684969 | Anxiety disorder | |
| 126849691 | 12684969 | Back pain | |
| 126849691 | 12684969 | Hyperlipidaemia | |
| 126849691 | 12684969 | Skin ulcer | |
| 126849691 | 12684969 | Spondylolisthesis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126849691 | 12684969 | 1 | 20130821 | 0 | ||
| 126849691 | 12684969 | 2 | 20130821 | 0 | ||
| 126849691 | 12684969 | 3 | 20130821 | 0 | ||
| 126849691 | 12684969 | 4 | 20130821 | 0 | ||
| 126849691 | 12684969 | 5 | 20130618 | 0 | ||
| 126849691 | 12684969 | 6 | 20140403 | 0 | ||
| 126849691 | 12684969 | 7 | 20150420 | 0 | ||
| 126849691 | 12684969 | 8 | 20160603 | 0 |